Mediator modulation therapy of severe sepsis and septic shock: does it work?
Phillip Dellinger
R
R
Parrillo
Joseph E
JE
D016470:Bacteremia / Q000188:drug therapy* / Q000382:microbiology / Q000401:mortality; D003422:Critical Care / Q000379:methods; D016638:Critical Illness; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D008297:Male; D011379:Prognosis; D016032:Randomized Controlled Trials as Topic; D018570:Risk Assessment; D012772:Shock, Septic / Q000188:drug therapy* / Q000382:microbiology / Q000401:mortality; D016019:Survival Analysis; D018746:Systemic Inflammatory Response Syndrome / Q000517:prevention & control; D016896:Treatment Outcome; D019323:omega-N-Methylarginine / Q000008:administration & dosage*
D019323:omega-N-Methylarginine